- Home
- TNXP vs OIS Comparison
TNXP vs OIS Comparison
Compare TNXP & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- OIS
- Stock Information
- Founded
- TNXP 2007
- OIS 1995
- Country
- TNXP United States
- OIS United States
- Employees
- TNXP N/A
- OIS N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- OIS Metal Fabrications
- Sector
- TNXP Health Care
- OIS Industrials
- Exchange
- TNXP Nasdaq
- OIS Nasdaq
- Market Cap
- TNXP 335.6M
- OIS 333.9M
- IPO Year
- TNXP N/A
- OIS 2001
- Fundamental
- Price
- TNXP $28.35
- OIS $5.87
- Analyst Decision
- TNXP Buy
- OIS Buy
- Analyst Count
- TNXP 1
- OIS 2
- Target Price
- TNXP $70.00
- OIS $7.25
- AVG Volume (30 Days)
- TNXP 1.2M
- OIS 456.9K
- Earning Date
- TNXP 11-11-2025
- OIS 10-29-2025
- Dividend Yield
- TNXP N/A
- OIS N/A
- EPS Growth
- TNXP N/A
- OIS N/A
- EPS
- TNXP N/A
- OIS 0.11
- Revenue
- TNXP $9,831,000.00
- OIS $664,287,000.00
- Revenue This Year
- TNXP $14.79
- OIS N/A
- Revenue Next Year
- TNXP $933.49
- OIS $5.23
- P/E Ratio
- TNXP N/A
- OIS $52.87
- Revenue Growth
- TNXP N/A
- OIS N/A
- 52 Week Low
- TNXP $6.76
- OIS $3.08
- 52 Week High
- TNXP $130.00
- OIS $5.99
- Technical
- Relative Strength Index (RSI)
- TNXP 41.38
- OIS 62.96
- Support Level
- TNXP $26.89
- OIS $5.49
- Resistance Level
- TNXP $29.19
- OIS $5.76
- Average True Range (ATR)
- TNXP 2.18
- OIS 0.19
- MACD
- TNXP 0.39
- OIS 0.02
- Stochastic Oscillator
- TNXP 56.46
- OIS 99.00
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.